Secretory Leukocyte Protease Inhibitor (SLPI) Decreased the Celluler Expression of NF-Kβ and IL-1β on Wound Macrophages of Rattus novergicus Post Tooth Extraction
DOI:
https://doi.org/10.11594/jtls.06.03.05Keywords:
Tooth extraction, Inflammation, SLPI, Macrophages, NF-Kβ, IL-1βAbstract
Prevalence of tooth extraction or dental surgery was 48.5% of all dental care in Indonesia. Tooth extraction carries potential health risks and side effects such as pain, swelling, trismus and dysfunction of the oral cavity during recovery. Secretory leukocyte protease inhibitor (SLPI) is one of innate immunity proteins that can inhibit the activation of macrophages. We are expecting the provision of SLPI can decrease excessive inflammatory response in healing after tooth extraction. This study was to investigate the administration of SLPI on cellular expression of NF-Kβ and IL-1β on wound macrophages of Rattus novergicus post tooth extraction. The research design is in vivo experimental study. In total, 20 rats were randomly divided into four groups (each group n=5) and underwent tooth extraction on left incisor teeth of mandible. One of the groups did not receive SLPI administration (control group) and the socket was stitched after tooth extraction. Meanwhile, the remaining three groups (experimental groups) were given SLPI administration after tooth extraction with three different doses (0.1 µM, 0.5 µM and 2.5 µM, respectively). After SLPI administration, the socket of experimental groups was stitched. The effects of SLPI administration were evaluated by counting at the percentage of NF-Kβ translocation and the expression of expression of IL-1 in macrophages cells of the rat socket using immunohistochemistry analysis. The cellular expression of NF-Kβ and IL-1β were significantly decreased (p < 0.05) on groups with SLPI may decrease cellular expression of NF-Kβ and IL-1β on wound macrophages cells of rats post tooth extraction in a dosedependent manner.References
Riset Kesehatan Dasar (2007). Badan Penelitian dan Pengembangan Kesehatan, Jakarta. Departemen Kesehatan, Republik Indonesia.
Dinarello Charles (2011) Interleukin-1 in the pathogenesis and treatment of inflammatory disease. Blood 117: 3720-3732.
Taggard CC, Catherine MG, Noel GME et al. (2002) Secretory Leucoprotease Inhibitor Prevents Lipopolysaccharide induced IkB Degradation without Affecting Phosphorylation or Ubiquitination. The Journal of Biological Chemistry. 277: 33648–33653.
Angelov N, Niki M, Moon-Jin J et al. (2004) Aberrant
mucosal wound repair in the absence of secretory
leukocyte protease inhibitor. Thromb Haemost. 92: 288–
Thuraisingam T, Hakeem S, Jacques M (2006) Delayed cutaneous wound healing in mice lacking solute carrier 11a1 (Formerly Nramp1): correlation with decreased expression of secretory leukocyte protease inhibitor. Journal of Investigative Dermatology 126: 890–901.
Sano C, Shimizu T (2003) Effects of secretory leukocyte protease inhibitor on the tumor necrosis factoralpha production and NF-Kβ activation of lipopolysaccharide-stimulated macrophages. Cytokine.
Ghasemlou N, Delphine B, Jingxuan Y et al. (2010) Beneficial effects of secretory leukocyte protease inhibitor after spinal cord injury. Brain: Journal of Neurology. 133: 126–138.
Song BX, Li Z, Wenwen J et al. (1999) Secretory leukocyte protease inhibitor suppresses the inflammation and joint damage of bacterial cell wall–induced arthritis. The Journal of Experimental Medicine. 190: 535–542.
Monick MM, Hunninghake GW (2002) Activation of second messenger pathways in alveolar macrophages by endotoxin. European Respiratory Journal. 20: 210-222.
Lawrence T (2009) The nuclear factor NF-Kβ pathway in inflammation. Cold Spring Harb Perspect Biol. 1: a001651, 1-10.
Andrew RC, Seng S, Semple JW et al. (2007) A role for IL-1 receptor antagonist or other cytokines in the acute therapeutic effects of IVIg. Hemostasis, Thrombosis, and Vascular Biology-Blood Journal 109:155-158.
Eming SA, Krieg T, Davidson JM (2007) Inflammation in wound repair: molecular and cellular mechanisms. Journal of Investigative Dermatology 127: 514–525.
Murata E, Sharmin S, Shiota H et al. (2003) The effect of topically applied secretory leukocyte protease inhibitor on the eosinophil response in the late phase of allergic conjunctivitis. Current Eye Research 26(5):271-276.
Taggard CC, Catherine MG, Noel GME et al. (2002)
Secretory leucoprotease inhibitor prevents Lipopolysaccharide induced IkB degradation without affecting phosphorylation or ubiquitination. The Journal of Biological Chemistry 277: 33648–33653.
Doumas S, Alexandros K, Panagiotis S (2005) Antiinflammatory and antimicrobial roles of secretory leukocyte protease inhibitor. Infection and Immunity 1271–1274.
Lentsch AB, Jacqueline A, Jordan BJC et al. (1999) Inhibition of NF-Kβ Activation and Augmentation of IkBβ by Secretory Leukocyte Protease Inhibitor during Lung Inflammation. American Journal of Pathology 154 (1): 239-247.
Taggart CC, Sally-Ann C, Sinead W et al. (2005) Secretory leucoprotease inhibitor binds to NF-kβ binding sites in monocytes and inhibits p65 binding. JEM 202: 1659–1668.
Downloads
Published
Issue
Section
License
The work has not been published before (except in the form of an abstract or part of a published lecture or thesis) and it is not under consideration for publication elsewhere. When the manuscript is accepted for publication in this journal, the authors agree to automatic transfer of the copyright to the publisher.
Journal of Tropical Life Science is licensed under Creative Commons Attribution-NonCommercial 4.0 International License
_.png){kind=logo}
